Monolayer C 60 networks: a first-principles perspective
Chemical Communications · 2025 · 61 (56) · 10287-10302
DOI: 10.1039/d5cc02473k ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Communications, 2025. Verfasst von Bo Peng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Theory of Condensed Matter Group, Cavendish Laboratory, University of Cambridge, J. J. Thomson Avenue, Cambridge CB3 0HE, UK. bp432@cam.ac.uk. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 255 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Engineering and Physical Sciences Research Council, Science and Technology Facilities Council.
Abstract (Originalsprache)
In this Feature article, we review three aspects of monolayer C 60 networks based on our recent first-principles calculations: (1) Are these monolayers stable? (2) Are they promising photocatalysts? (3) Are their chemical functionalities tuneable?
Autor:innen und Institutionen
- Theory of Condensed Matter Group, Cavendish Laboratory, University of Cambridge, J. J. Thomson Avenue, Cambridge CB3 0HE, UK. bp432@cam.ac.uk.
- Department of Physics, University of Bath, Bath BA2 7AY, UK. mp2834@bath.ac.uk.
- School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts 02138, USA.
Förderung
- Engineering and Physical Sciences Research Council
- Science and Technology Facilities Council
Zitieren
APA
Peng, B., & Pizzochero, M. (2025). Monolayer C 60 networks: a first-principles perspective. Chemical Communications, 61(56), 10287-10302. https://doi.org/10.1039/d5cc02473k
Vancouver
Peng B, Pizzochero M. Monolayer C 60 networks: a first-principles perspective. Chemical Communications. 2025;61(56):10287-10302. doi:10.1039/d5cc02473k
BibTeX
@article{Peng2025,
author = {Peng, Bo and Pizzochero, Michele},
title = {Monolayer C 60 networks: a first-principles perspective},
journal = {Chemical Communications},
year = {2025},
volume = {61},
number = {56},
pages = {10287--10302},
doi = {10.1039/d5cc02473k}
}
EUVIMED